Clinical Breast Cancer is a peer-reviewed bimonthly journal that publishes original articles describing various aspects of clinical and translational research of breast cancer. Clinical Breast Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of breast cancer. The main emphasis is on recent scientific developments in all areas related to breast cancer. Specific areas of interest include clinical research reports from various therapeutic modalities, cancer genetics, drug sensitivity and resistance, novel imaging, tumor genomics, biomarkers, and chemoprevention strategies.
《临床乳腺癌》是一份同行评审的双月刊杂志，发表描述乳腺癌临床和转化研究各个方面的原创文章。《临床乳腺癌》致力于发表关于乳腺癌的检测、诊断、预防和治疗的文章。主要重点是最近与乳腺癌有关的所有领域的科学发展。感兴趣的特定领域包括各种治疗模式的临床研究报告、癌症遗传学、药物敏感性和耐药性、新型成像、肿瘤基因组学、生物标志物和化学预防策略。
Combined Targeted Therapies for First‐line Treatment of Metastatic Triple Negative Breast Cancer—A Phase II Trial of Weekly Nab‐Paclitaxel and Bevacizumab Followed by Maintenance Targeted Therapy With Bevacizumab and Erlotinib
来源期刊：Clinical Breast CancerDOI：10.1016/j.clbc.2018.12.008
The Impact of Vaginal Laser Treatment for Genitourinary Syndrome of Menopause in Breast Cancer Survivors: A Systematic Review and Meta-analysis.
来源期刊：Clinical breast cancerDOI：10.1016/J.CLBC.2019.04.007
Beliefs About Medication and Uptake of Preventive Therapy in Women at Increased Risk of Breast Cancer: Results From a Multicenter Prospective Study
来源期刊：Clinical Breast CancerDOI：10.1016/j.clbc.2018.10.008
Dietary Habits and Physical Activity are Associated With the Risk of Breast Cancer Among Young Iranian Women: A Case‐control Study on 1010 Premenopausal Women
来源期刊：Clinical Breast CancerDOI：10.1016/j.clbc.2018.10.011
Breast Cancer in Women Aged 80 Years or Older: An Analysis of Treatment Patterns and Disease Outcomes.
来源期刊：Clinical breast cancerDOI：10.1016/j.clbc.2019.01.007
Phase II Study of Systemic High-dose Methotrexate and Intrathecal Liposomal Cytarabine for Treatment of Leptomeningeal Carcinomatosis From Breast Cancer.
来源期刊：Clinical breast cancerDOI：10.1016/J.CLBC.2019.04.004
Incidence of Brain Metastases in Nonmetastatic and Metastatic Breast Cancer: Is There a Role for Screening?
来源期刊：Clinical breast cancerDOI：10.1016/J.CLBC.2019.06.007
Symptoms Predictive of Overall Quality of Life Using the Edmonton Symptom Assessment Scale in Breast Cancer Patients Receiving Radiotherapy.
来源期刊：Clinical breast cancerDOI：10.1016/J.CLBC.2019.05.007
Radical Mastectomy Increases Psychological Distress in Young Breast Cancer Patients: Results of A Cross‐sectional Study
来源期刊：Clinical Breast CancerDOI：10.1016/j.clbc.2018.08.013
Features Associated With Long-Term Survival in Patients With Metastatic Breast Cancer.
来源期刊：Clinical breast cancerDOI：10.1016/j.clbc.2019.01.014
Characteristics and Outcomes of BI‐RADS 3 Lesions on Breast MRI
来源期刊：Clinical Breast CancerDOI：10.1016/j.clbc.2018.08.011
Phase II, Multicenter, Single‐arm Trial of Eribulin as First‐line Therapy for Patients With Aggressive Taxane‐pretreated HER2‐Negative Metastatic Breast Cancer: The MERIBEL Study
来源期刊：Clinical Breast CancerDOI：10.1016/j.clbc.2018.12.012
Association of Serum Progranulin Levels With Disease Progression, Therapy Response and Survival in Patients With Metastatic Breast Cancer.
来源期刊：Clinical breast cancerDOI：10.1016/j.clbc.2019.11.010
MicroRNA-4472 Promotes Tumor Proliferation and Aggressiveness in Breast Cancer by Targeting RGMA and Inducing EMT.
来源期刊：Clinical breast cancerDOI：10.1016/j.clbc.2019.08.010
A Phase II Open Label Study of Everolimus in Combination With Endocrine Therapy in Resistant Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer.
来源期刊：Clinical breast cancerDOI：10.1016/J.CLBC.2019.06.005
Efficacy of Neoadjuvant Endocrine Therapy Versus Neoadjuvant Chemotherapy in ER-positive Breast Cancer: Results From a Prospective Institutional Database.
来源期刊：Clinical breast cancerDOI：10.1016/j.clbc.2019.05.020
The Safety of Local Hormonal Treatment for Vulvovaginal Atrophy in Women With Estrogen Receptor-positive Breast Cancer Who Are on Adjuvant Aromatase Inhibitor Therapy: Meta-analysis.
来源期刊：Clinical breast cancerDOI：10.1016/J.CLBC.2019.07.007
Individualized Prediction of Menses Recovery After Chemotherapy for Early‐stage Breast Cancer: A Nomogram Developed From UNICANCER PACS04 and PACS05 Trials
来源期刊：Clinical Breast CancerDOI：10.1016/j.clbc.2018.08.005
Implementing a Population-Based Breast Cancer Risk Assessment Program.
来源期刊：Clinical breast cancerDOI：10.1016/J.CLBC.2019.02.009
Aggressive Surgical Excision of Supraclavicular Lymph Node Did Not Improve the Outcomes of Breast Cancer With Supraclavicular Lymph Node Involvement (KROG 16-14).
来源期刊：Clinical breast cancerDOI：10.1016/j.clbc.2019.09.004
Meta‐analysis of the Correlation Between Schizophrenia and Breast Cancer
来源期刊：Clinical Breast CancerDOI：10.1016/j.clbc.2018.10.012
Extended Adjuvant Therapy With Aromatase Inhibitors for Early Breast Cancer: A Meta-analysis of Randomized Controlled Trials.
来源期刊：Clinical breast cancerDOI：10.1016/J.CLBC.2019.03.005
Impact of 21‐Gene Expression Assay on Staging Estrogen Receptor–Positive HER2‐Negative Breast Cancer
来源期刊：Clinical Breast CancerDOI：10.1016/j.clbc.2018.10.005
The HERBA Study: A Retrospective Multi-Institutional Italian Study on Patients With Brain Metastases From HER2-Positive Breast Cancer.
来源期刊：Clinical breast cancerDOI：10.1016/J.CLBC.2019.05.006
Germline Genetic Variants in GATA3 and Breast Cancer Treatment Outcomes in SWOG S8897 Trial and the Pathways Study.
来源期刊：Clinical breast cancerDOI：10.1016/J.CLBC.2019.02.010
Metabolic Characterization of Inflammatory Breast Cancer With Baseline FDG‐PET/CT: Relationship With Pathologic Response After Neoadjuvant Chemotherapy, Receptor Status, and Tumor Grade
来源期刊：Clinical Breast CancerDOI：10.1016/j.clbc.2018.11.010
Timeliness of Treatment Initiation in Newly Diagnosed Patients With Breast Cancer.
来源期刊：Clinical breast cancerDOI：10.1016/J.CLBC.2019.06.009
Screening Mammography Findings in Women With Chronic Kidney Disease on a Renal Transplant Waiting List.
来源期刊：Clinical breast cancerDOI：10.1016/j.clbc.2019.01.009
The Undervalued Effects of Polychlorinated Biphenyl Exposure on Breast Cancer.
来源期刊：Clinical breast cancerDOI：10.1016/J.CLBC.2019.07.005
Intensive Imaging Surveillance of Survivors of Breast Cancer May Increase Risk of Radiation-induced Malignancy.
来源期刊：Clinical breast cancerDOI：10.1016/j.clbc.2019.01.003
Implementation of a Multidisciplinary Model of Care for Women With Metastatic Breast Cancer: Challenges and Lessons Learned
来源期刊：Clinical Breast CancerDOI：10.1016/j.clbc.2018.12.014
Evaluation of Therapeutic Target Gene Expression Based on Residual Cancer Burden Classification After Neoadjuvant Chemotherapy for HER2-Negative Breast Cancer.
来源期刊：Clinical breast cancerDOI：10.1016/j.clbc.2019.07.001
Mammography Coverage and Tumor Stage in the Opportunistic Screening Context.
来源期刊：Clinical breast cancerDOI：10.1016/J.CLBC.2019.04.014
Oncoplastic Breast Surgery Compared to Conventional Breast-Conserving Surgery With Regard to Oncologic Outcome.
来源期刊：Clinical breast cancerDOI：10.1016/J.CLBC.2019.05.016
Body Mass Index and Hormone Receptor Status Influence Recurrence Risk in HER2-Positive Early Breast Cancer Patients.
来源期刊：Clinical breast cancerDOI：10.1016/J.CLBC.2019.06.008
Hormone Receptor and Human Epidermal Growth Factor Receptor 2 Detection in Invasive Breast Carcinoma: A Retrospective Study of 12,467 Patients From 19 Chinese Representative Clinical Centers.
来源期刊：Clinical breast cancerDOI：10.1016/J.CLBC.2019.07.013
Long-Term Follow-up of Immediate Latissimus Dorsi Flap Reconstruction After Neoadjuvant Chemotherapy and Radiotherapy for Invasive Breast Cancer.
来源期刊：Clinical breast cancerDOI：10.1016/J.CLBC.2019.03.007
Comparison of Radio-guided Occult Lesion Localization (ROLL) and Magnetic Occult Lesion Localization (MOLL) for Non-palpable Lesions: A Phantom Model Study.
来源期刊：Clinical breast cancerDOI：10.1016/j.clbc.2019.09.002
Isolated Tumor Cells in Sentinel Lymph Nodes of Primary Invasive Breast Carcinoma: A Cohort Analysis.
来源期刊：Clinical breast cancerDOI：10.1016/J.CLBC.2019.03.002
Implant-sparing Mastectomy: An Alternative for Women Undergoing Mastectomy With Retropectoral Implants.
来源期刊：Clinical breast cancerDOI：10.1016/j.clbc.2019.08.007
Effectiveness of Adjuvant Ovarian Function Suppression in Premenopausal Women With Early Breast Cancer: A Multicenter Cohort Study.
来源期刊：Clinical breast cancerDOI：10.1016/j.clbc.2019.06.003
Prophylactic Versus Therapeutic Mastectomy: A Contemporary Analysis of the ACS-NSQIP Database.
来源期刊：Clinical breast cancerDOI：10.1016/j.clbc.2019.01.008
The Impact of a Postmastectomy Chest Wall Scar Boost on Local Recurrence-free Survival in High-risk Patients.
来源期刊：Clinical breast cancerDOI：10.1016/J.CLBC.2019.04.010
Development of Phase-Specific Breast Cancer Survivorship Care Plans.
来源期刊：Clinical breast cancerDOI：10.1016/J.CLBC.2019.05.017
New Cardiac Abnormalities After Radiotherapy in Breast Cancer Patients Treated With Trastuzumab.
来源期刊：Clinical breast cancerDOI：10.1016/j.clbc.2019.12.006
Radiotherapy After Skin-Sparing Mastectomy and Implant-Based Breast Reconstruction.
来源期刊：Clinical breast cancerDOI：10.1016/J.CLBC.2019.04.002
Longer Times of Receipt of Adjuvant Endocrine Therapy Correspond to Improved Functional Capacity and Lower Adiposity in Women Receiving Adjuvant Therapy
来源期刊：Clinical Breast CancerDOI：10.1016/j.clbc.2018.09.003
Our Radiological Experience on B3 Lesions: Correlation Between Mammographic and MRI Findings With Histologic Definitive Result.
来源期刊：Clinical breast cancerDOI：10.1016/J.CLBC.2019.06.004
LOC643714 Polymorphisms Contribute to an Elevated Susceptibility to Breast Cancer: A Meta-analysis of 231,191 Subjects.
来源期刊：Clinical breast cancerDOI：10.1016/J.CLBC.2019.04.016
Frequency of Immune Cell Subtypes in Peripheral Blood Correlates With Outcome for Patients With Metastatic Breast Cancer Treated With High-Dose Chemotherapy.
来源期刊：Clinical breast cancerDOI：10.1016/J.CLBC.2019.05.002
